RAGE and Diaph1 deficiency affect retinal cytoarchitecture both in physiological and long-term hyperglycemic settings in diabetic mice – a preliminary study
Polish Journal of Veterinary Sciences · 17.03.2026 · 127-127
DOI: 10.24425/pjvs.2026.158507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Journal of Veterinary Sciences, online erschienen am 17.03.2026. Verfasst von P Mizia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-085 Olsztyn, Po…. Hauptthemen laut MEDLINE: Retina, Diabetes Mellitus, Experimental, Receptor for Advanced Glycation End Products, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Retinal complications in diabetes are a leading cause of vision loss in adults. Long-term hyperglycemia triggers molecular changes that damage retinal neuronal tissues and blood vessels, leading to degeneration, inflammation, and vision impairment. Studies show that the Receptor for Advanced Glycation End-Products (RAGE) and its cytosolic ligand, Diaph1 are both implicated in the pathogenesis of diabetic complications; however, their role in the development of retinal damage is not yet clear. We hypothesized that the deletion of either RAGE or Diaph1 would be beneficial and prevent or delay damage to the retinal structure in diabetes. Wild-type, RAGE and Diaph1 knockout mice were used in the study. The mice were randomly selected and divided into control and diabetic groups. Diabetes was induced with Streptozotocin injections, and six months after diabetes induction all mice were sacrificed, samples collected and processed for morphometric analysis. Our analysis revealed a reduction in retinal depth across all layers between control and diabetic samples. The effect of RAGE or Diaph1 deletion on retinal structure differed, indicating that both proteins may play independent if not interchangeable roles in retina function and structure, highlighting their potential role in the pathogenesis of diabetic retinal complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-085 Olsztyn, Poland.
- Department of Biological Functions of Food, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Władysława Trylińskiego 18, 10-683 Olsztyn, Poland.
- Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-713 Olsztyn, Poland.
- Department of Pathophysiology, Forensic and Administration of Veterinary Medicine, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-713 Olsztyn, Poland.
Zitieren
APA
Mizia, P., Kordas, B., Mazur, U., Jarosławska-Miszkiewicz, J., Szyryńska, N., Wąsowicz, K., & Juranek, J. K. (2026). RAGE and Diaph1 deficiency affect retinal cytoarchitecture both in physiological and long-term hyperglycemic settings in diabetic mice – a preliminary study. Polish Journal of Veterinary Sciences, 127-127. https://doi.org/10.24425/pjvs.2026.158507
Vancouver
Mizia P, Kordas B, Mazur U, Jarosławska-Miszkiewicz J, Szyryńska N, Wąsowicz K, et al. RAGE and Diaph1 deficiency affect retinal cytoarchitecture both in physiological and long-term hyperglycemic settings in diabetic mice – a preliminary study. Polish Journal of Veterinary Sciences. 2026:127-127. doi:10.24425/pjvs.2026.158507
BibTeX
@article{Mizia2026,
author = {Mizia, P and Kordas, B and Mazur, U and Jarosławska-Miszkiewicz, J and Szyryńska, N and Wąsowicz, K and Juranek, J K},
title = {RAGE and Diaph1 deficiency affect retinal cytoarchitecture both in physiological and long-term hyperglycemic settings in diabetic mice – a preliminary study},
journal = {Polish Journal of Veterinary Sciences},
year = {2026},
pages = {127--127},
doi = {10.24425/pjvs.2026.158507}
}
EUVIMED